risperidone / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

7 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
risperidone / Generic mfg.
2006-004783-31: A Double-Blind, Randomised, Parallel-Group, Placebo-Controlled, MultiCentre, Phase IIa Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Multiple Oral Doses of AZD3480 in Schizophrenic Patients on Stable Antipsychotic Monotherapy with quetiapine, risperidone or olanzapine

Ongoing
2
50
Europe
AZD3480,
AstraZeneca AB
Schizophrenia
 
 
2020-000094-24: A Phase 2B Randomized, Double-Blind, Placebo- and Active-Controlled Trial of the Efficacy and Safety of MK-8189 in Participants Experiencing an Acute Episode of Schizophrenia

Ongoing
2
576
Europe, RoW
Risperidone, MK-8189, Tablet, Capsule, Risperdal (Risperdione)
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
CLOZ-AID, NCT04529226: Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis

Active, not recruiting
2
75
Europe
Clozapine, Nemex, Leponex, haloperidol, pimozide, olanzapine, risperidone, amisulpride
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Psychosis, Intellectual Disability
01/25
12/25
MK-8189-008, NCT04624243 / 2020-000094-24: Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia

Active, not recruiting
2
500
Europe, Japan, US, RoW
MK-8189, Risperidone, Placebo to MK-8189, Placebo to risperidone
Merck Sharp & Dohme LLC, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Schizophrenia
07/24
07/24
NCT04105231: Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use

Recruiting
2
130
Europe
Cannabidiol, Epidiolex, Risperidone, Risperidon
Lone Baandrup, Danish Center for Sleep Medicine, Copenhagen University Hospital, Denmark, Glostrup University Hospital, Copenhagen, University of Copenhagen
Dual Diagnosis
12/24
06/25
PSI-RIS, NCT05710237: Does Psilocybin Require Psychedelic Effects to Treat Depression?

Recruiting
2
60
Canada
Psilocybin 25 mg, Risperidone 1 MG, Placebo
Centre for Addiction and Mental Health
Treatment-resistant Depression
02/26
02/26
OCD-RT, NCT05401019: Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD)

Not yet recruiting
2
52
NA
Pramipexole, Risperidone
Clinical Academic Center (2CA-Braga), University of Minho
Obsessive-Compulsive Disorder
12/26
12/26

Download Options